These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 2608880)

  • 1. Vasculitis complicating cystic fibrosis.
    Finnegan MJ; Hinchcliffe J; Russell-Jones D; Neill S; Sheffield E; Jayne D; Wise A; Hodson ME
    Q J Med; 1989 Jul; 72(267):609-21. PubMed ID: 2608880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti-Pseudomonas aeruginosa antibodies, circulating immune complexes, and anticytoplasm antibodies of neutrophils in patients with cystic fibrosis with and without Pseudomonas aeruginosa colonization].
    Chiappini E; Taccetti G; Campana S; Turchini S; Marianelli L
    Pediatr Med Chir; 2001; 23(1):27-30. PubMed ID: 11486418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulomatous cutaneous rheumatoid vasculitis.
    Callen JP; Ahrens EM
    J Rheumatol; 1988 Jun; 15(6):1005-8. PubMed ID: 3418621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Episodic arthropathy in adult cystic fibrosis.
    Bourke S; Rooney M; Fitzgerald M; Bresnihan B
    Q J Med; 1987 Aug; 64(244):651-9. PubMed ID: 3444871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digital vasculitis in patients with cryptogenic fibrosing alveolitis.
    Hodson ME; Haslam PL; Spiro SG; Turner-Warwick M
    Br J Dis Chest; 1984 Apr; 78(2):140-8. PubMed ID: 6722017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cystic fibrosis associated cutaneous vasculitis with chloroquine.
    Molyneux ID; Moon T; Webb AK; Morice AH
    J Cyst Fibros; 2010 Dec; 9(6):439-41. PubMed ID: 20863769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antineutrophil cytoplasmic antibodies in cystic fibrosis. Frequency and significance].
    Berlie I; Leboucher B; Leblanc M; Troussier F; Pellier I; Chevailler A; Giniès JL
    Arch Pediatr; 2005 Feb; 12(2):140-3. PubMed ID: 15694536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Ratjen F; Walter H; Haug M; Meisner C; Grasemann H; Döring G
    Pediatr Pulmonol; 2007 Mar; 42(3):249-55. PubMed ID: 17243185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous vasculitis: diagnosis and management.
    Carlson JA; Cavaliere LF; Grant-Kels JM
    Clin Dermatol; 2006; 24(5):414-29. PubMed ID: 16966021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum bactericidal test as a prognostic indicator in acute pulmonary exacerbations of cystic fibrosis.
    Cahen P; Le Bourgeois M; Delacourt C; Coustère C; Nicaise P; de Blic J; Véron M; Scheinmann P; Gaillard JL
    Pediatrics; 1993 Feb; 91(2):451-5. PubMed ID: 8424026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Isolation frequency of Burkholderia cepacia from cystic fibrosis patients].
    Ocak F; Gözalan A; Ozçelik U; Anadol D; Kiper N; Aktepe OC; Göçmen A; Esen B
    Mikrobiyol Bul; 2002 Jan; 36(1):1-10. PubMed ID: 12476760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antineutrophil cytoplasmic antibodies and associated diseases].
    Sghiri R; Meddeb H; Bouguila J; Jarray M; Bahri F; Nouira R; Zellama D; Achour A; Essoussi AS; Harbi A; Ghedira I
    Pathol Biol (Paris); 2009 Jul; 57(5):398-402. PubMed ID: 18834675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antimicrobial susceptibility of bacterial isolates from patients with cystic fibrosis].
    García AD; Ibarra A; Rodríguez FC; Casal M
    Rev Esp Quimioter; 2004 Dec; 17(4):332-5. PubMed ID: 15696223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases.
    Sanchez NP; Van Hale HM; Su WP
    Arch Dermatol; 1985 Feb; 121(2):220-4. PubMed ID: 2858179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic antineutrophil cytoplasmic antibody-positive vasculitis associated with ulcerative colitis.
    Weir A; Taylor-Robinson SD; Poole S; Pignatelli M; Walters JF; Calam J
    Am J Gastroenterol; 1997 Mar; 92(3):506-8. PubMed ID: 9068480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation and identification of Burkholderia cepacia complex from cystic fibrosis patients].
    Yurdakul P; Ergünay K; Yalçin E; Doğru D; Sener B; Cobanoğlu N; Ozçelik U; Kiper N
    Mikrobiyol Bul; 2006 Oct; 40(4):301-6. PubMed ID: 17205687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineutrophil cytoplasmic antibodies (ANCA) and the systemic necrotizing vasculitides.
    Robinson AJ
    Nephrol Dial Transplant; 1994; 9(2):119-26. PubMed ID: 8190324
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous manifestations of cystic fibrosis.
    Bernstein ML; McCusker MM; Grant-Kels JM
    Pediatr Dermatol; 2008; 25(2):150-7. PubMed ID: 18429769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transtracheal aspiration in pulmonary infection in children with cystic fibrosis.
    Brook I; Fink R
    Eur J Respir Dis; 1983 Jan; 64(1):51-7. PubMed ID: 6825749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.